Page last updated: 2024-09-05

sb 203580 and Latent Tuberculosis

sb 203580 has been researched along with Latent Tuberculosis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Barnes, PF; Peng, H; Samten, B; Tang, H; Townsend, JC; Wang, X	1

Other Studies

1 other study(ies) available for sb 203580 and Latent Tuberculosis

Article	Year
The Mycobacterium tuberculosis early secreted antigenic target of 6 kDa inhibits T cell interferon-γ production through the p38 mitogen-activated protein kinase pathway. The Journal of biological chemistry, 2011, Jul-08, Volume: 286, Issue:27 Topics: Antigens, Bacterial; Bacterial Proteins; Cell Proliferation; Cells, Cultured; Enzyme Inhibitors; Gene Silencing; Humans; Imidazoles; Interferon-gamma; Interleukin-10; Interleukin-17; Latent Tuberculosis; MAP Kinase Kinase 4; Mycobacterium tuberculosis; p38 Mitogen-Activated Protein Kinases; Proto-Oncogene Proteins c-akt; Pyridines; T-Lymphocytes	2011

Article

Year

The Mycobacterium tuberculosis early secreted antigenic target of 6 kDa inhibits T cell interferon-γ production through the p38 mitogen-activated protein kinase pathway.

The Journal of biological chemistry, 2011, Jul-08, Volume: 286, Issue:27

Topics: Antigens, Bacterial; Bacterial Proteins; Cell Proliferation; Cells, Cultured; Enzyme Inhibitors; Gene Silencing; Humans; Imidazoles; Interferon-gamma; Interleukin-10; Interleukin-17; Latent Tuberculosis; MAP Kinase Kinase 4; Mycobacterium tuberculosis; p38 Mitogen-Activated Protein Kinases; Proto-Oncogene Proteins c-akt; Pyridines; T-Lymphocytes

2011